Arcosa Stock Forecast, Price & News

Arcosa (NYSE:ACA) Frequently Asked Questions

Is Arcosa a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Arcosa in the last twelve months. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Arcosa stock.
View analyst ratings for Arcosa or view top-rated stocks.

What stocks does MarketBeat like better than Arcosa?

Wall Street analysts have given Arcosa a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Arcosa wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Arcosa?

Arcosa saw a increase in short interest in the month of August. As of August 13th, there was short interest totaling 1,470,000 shares, an increase of 126.1% from the July 29th total of 650,200 shares. Based on an average daily volume of 243,500 shares, the days-to-cover ratio is currently 6.0 days. Currently, 3.1% of the company's stock are sold short.
View Arcosa's Short Interest.

When is Arcosa's next earnings date?

Arcosa is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for Arcosa.

How were Arcosa's earnings last quarter?

Arcosa, Inc. (NYSE:ACA) posted its quarterly earnings results on Tuesday, August, 3rd. The company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.57 by $0.03. The business had revenue of $515.10 million for the quarter, compared to analysts' expectations of $491.65 million. Arcosa had a trailing twelve-month return on equity of 5.08% and a net margin of 4.12%. Arcosa's quarterly revenue was up 3.3% on a year-over-year basis. During the same period last year, the company posted $0.68 earnings per share.
View Arcosa's earnings history.

How has Arcosa's stock been impacted by COVID-19?

Arcosa's stock was trading at $37.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ACA shares have increased by 32.0% and is now trading at $48.88.
View which stocks have been most impacted by COVID-19.

How often does Arcosa pay dividends? What is the dividend yield for Arcosa?

Arcosa announced a quarterly dividend on Friday, September 3rd. Investors of record on Friday, October 15th will be given a dividend of $0.05 per share on Friday, October 29th. This represents a $0.20 annualized dividend and a yield of 0.41%. The ex-dividend date of this dividend is Thursday, October 14th.
View Arcosa's dividend history.

Is Arcosa a good dividend stock?

Arcosa pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.40%. Arcosa does not yet have a strong track record of dividend growth. The dividend payout ratio of Arcosa is 8.16%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Arcosa will have a dividend payout ratio of 7.97% next year. This indicates that Arcosa will be able to sustain or increase its dividend.
View Arcosa's dividend history.

What guidance has Arcosa issued on next quarter's earnings?

Arcosa issued an update on its FY 2021 earnings guidance on Friday, September, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.95 billion-$2.05 billion, compared to the consensus revenue estimate of $1.93 billion.

What price target have analysts set for ACA?

7 analysts have issued 12-month target prices for Arcosa's stock. Their forecasts range from $60.00 to $75.00. On average, they anticipate Arcosa's share price to reach $69.00 in the next twelve months. This suggests a possible upside of 41.2% from the stock's current price.
View analysts' price targets for Arcosa or view top-rated stocks among Wall Street analysts.

Who are Arcosa's key executives?

Arcosa's management team includes the following people:

• Antonio Carrillo Rule, President, Chief Executive Officer & Director
• Gail M. Peck, Chief Financial Officer
• Reid S. Essl, President-Construction Products
• Kerry S. Cole, President-Energy Equipment
• Jess E. Collins, President-Transportation Products

What is Antonio Carrillo's approval rating as Arcosa's CEO?

15 employees have rated Arcosa CEO Antonio Carrillo on Glassdoor.com. Antonio Carrillo has an approval rating of 91% among Arcosa's employees. This puts Antonio Carrillo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Arcosa's key competitors?

Some companies that are related to Arcosa include Valmont Industries (VMI), Proto Labs (PRLB), Altimar Acquisition Corp. II (ATMR), HC2 (HCHC), TechPrecision (TPCS), Gulf Island Fabrication (GIFI) and Williams Industries (WMSI).
View all of ACA's competitors.

What other stocks do shareholders of Arcosa own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcosa investors own include DexCom (DXCM), AbbVie (ABBV), The Walt Disney (DIS), Advanced Micro Devices (AMD), NVIDIA (NVDA), Splunk (SPLK), AT&T (T), Xilinx (XLNX), Activision Blizzard (ATVI) and Alibaba Group (BABA).

What is Arcosa's stock symbol?

Arcosa trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACA."

Who are Arcosa's major shareholders?

Arcosa's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.64%), Vanguard Group Inc. (10.50%), Capital International Investors (5.50%), Dimensional Fund Advisors LP (4.07%), State Street Corp (3.63%) and Capital International Inc. CA (3.24%). Company insiders that own Arcosa stock include Antonio Carrillo, Jesse E Jr Collins, Kerry S Cole, Mary E Henderson and Ronald J Gafford.
View institutional ownership trends for Arcosa.

Which institutional investors are selling Arcosa stock?

ACA stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Capital International Inc. CA, JPMorgan Chase & Co., Ancora Advisors LLC, California Public Employees Retirement System, Bank of America Corp DE, Ergoteles LLC, and State Street Corp. Company insiders that have sold Arcosa company stock in the last year include Jesse E Jr Collins, Mary E Henderson, and Ronald J Gafford.
View insider buying and selling activity for Arcosa or view top insider-selling stocks.

Which institutional investors are buying Arcosa stock?

ACA stock was acquired by a variety of institutional investors in the last quarter, including Capital International Investors, American Century Companies Inc., Granite Investment Partners LLC, FMR LLC, Price T Rowe Associates Inc. MD, Victory Capital Management Inc., Northern Trust Corp, and Vanguard Group Inc..
View insider buying and selling activity for Arcosa or or view top insider-buying stocks.

How do I buy shares of Arcosa?

Shares of ACA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Arcosa's stock price today?

One share of ACA stock can currently be purchased for approximately $48.88.

How much money does Arcosa make?

Arcosa has a market capitalization of $2.37 billion and generates $1.94 billion in revenue each year. The company earns $106.60 million in net income (profit) each year or $2.45 on an earnings per share basis.

How many employees does Arcosa have?

Arcosa employs 6,410 workers across the globe.

What is Arcosa's official website?

The official website for Arcosa is www.arcosa.com.

Where are Arcosa's headquarters?

Arcosa is headquartered at 500 N. Akard Street Suite 400, DALLAS TX, 75201.

How can I contact Arcosa?

Arcosa's mailing address is 500 N. Akard Street Suite 400, DALLAS TX, 75201. The company can be reached via phone at (972) 942-6500 or via email at [email protected].